BIOMAT Database Logo BIOMAT Database Logo

Counseling HIV-antibody positive blood donors. 1987

N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D001771 Blood Banks Centers for collecting, characterizing and storing blood or plasma. Bank, Blood,Banks, Blood,Blood Bank
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D003142 Communication The exchange or transmission of ideas, attitudes, or beliefs between individuals or groups. Miscommunication,Misinformation,Social Communication,Communication Programs,Communications Personnel,Personal Communication,Communication Program,Communication, Personal,Communication, Social,Communications, Social,Miscommunications,Misinformations,Personnel, Communications,Program, Communication,Programs, Communication,Social Communications
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.
August 1988, American journal of public health,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
India: HIV-positive blood donors.
June 1993, Lancet (London, England),
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
HTLV-III antibody positive blood donors.
May 1985, Lancet (London, England),
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
Lessons learned this past year from HIV antibody testing and from counseling blood donors.
January 1986, Transfusion,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
The clinical and lymphocyte status of HIV antibody-positive black blood donors.
June 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
Trends in sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.
January 1991, AIDS education and prevention : official publication of the International Society for AIDS Education,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
[HIV-positive blood donors, 1985-1993].
May 1994, Nederlands tijdschrift voor geneeskunde,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
Hepatitis C virus antibody positive blood donors.
January 1993, Gut,
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
[Follow-up studies of donors and recipients of HIV antibody-positive blood products].
January 1987, Deutsche medizinische Wochenschrift (1946),
N L Van Devanter, and J A Grisaffi, and M Steilen, and M E Scarola, and R M Shipton, and C Tendler, and J Pindyck
[HIV-positive blood donors: an epidemiological survey].
October 1988, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!